介质素-2和型病毒疗法:癌症治疗的新视角
Parisa Shiri Aghbash1,2, Reyhaneh Rasizadeh1,2, Amir Hossein Yari1,3
1Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Anti-cancer agents in medicinal chemistry
|July 27, 2023
概括
将瘤性病毒与介质素-2 (IL-2) 结合起来,在癌症治疗方面显示出有前途. 这种方法通过在瘤微环境中触发免疫反应来增强抗瘤免疫力.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 病毒学 病毒学
背景情况:
- 免疫疗法对恶性瘤有效,但瘤会产生免疫抑制的环境.
- 恶性细胞表达配体和受体,阻碍抗癌免疫力.
- 结合治疗与瘤治疗病毒和IL-2等细胞因子提供了一个潜在的策略.
研究的目的:
- 审查IL-2在免疫反应中的作用.
- 检查结合型病毒与IL-2的影响.
- 为了评估这种联合治疗对恶性进展的评估.
主要方法:
- 关于IL-2功能和型病毒治疗的文献综述.
- 在瘤微环境中对免疫反应调节的分析.
- 评估细胞因子的释放和免疫细胞的积累.
主要成果:
- 瘤病毒诱导癌细胞死亡,并释放瘤抗原.
- 这个过程激活了淋巴细胞和抗原呈现细胞.
- IL-2增强了瘤内的这些免疫活动.
结论:
- 结合治疗与型病毒和IL-2可以克服瘤免疫抑制.
- 在增强抗瘤免疫力方面,IL-2的作用至关重要.
- 这种治疗策略在癌症治疗中需要进一步考虑.
相关概念视频
Tumor Immunotherapy
558
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
558
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Cancer Vaccines
405
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
405
Cytotoxic T Cells-mediated Immune Response
974
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
974
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


